Related Experiment Videos
Are schizophrenics with abnormal dexamethasone suppression test results a distinct subgroup?
Acta Psychiatrica Scandinavica
|September 1, 1985
Summary
Dexamethasone suppression test (DST) nonsuppression in schizophrenia appears to be a random event. Schizophrenic patients who did not suppress DST results showed no significant differences across various clinical and biological measures compared to suppressors.
Area of Science:
- Neuroscience
- Psychiatry
- Biomedical Research
Background:
- Nonsuppression on the dexamethasone suppression test (DST) has been previously reported in schizophrenic patients.
- The clinical and biological significance of DST nonsuppression in schizophrenia remains unclear.
Purpose of the Study:
- To investigate the significance of DST nonsuppression in schizophrenia by examining a cohort across multiple parameters.
- To determine if DST nonsuppressing schizophrenics differ from DST suppressing schizophrenics in various clinical and biological aspects.
Main Methods:
- A cohort of schizophrenic patients was assessed using computed tomography (CT), electroencephalography (EEG), and the Halstead-Reitan Neuropsychological Battery (HRB).
- Platelet monoamine oxidase activity (MAO) and serum dopamine-beta-hydroxylase (DBH) levels were measured.
- Premorbid personality adjustment, medication response, and family history of mental illness were also evaluated.
Main Results:
- No significant differences were found between DST nonsuppressing and DST suppressing schizophrenics across all tested parameters.
- This includes neuroimaging (CT, EEG), neuropsychological assessments (HRB), biochemical markers (MAO, DBH), and clinical factors.
Conclusions:
- The findings suggest that DST nonsuppression in schizophrenia is not associated with specific clinical or biological characteristics.
- DST nonsuppression in schizophrenic individuals appears to be a transient and unpredictable phenomenon.